GODAVARIB
Godavari Biorefineries Limited manufactures and sells sugar in India. It provides distillery, including ethanol, bio-chemicals, and other bio products; and classic and brown sugar, plantation white sugar, and refined sugar. The company also offers perfumery and pharmaceutical grade ethanol, rectified spirits, anhydrous alcohol, and extra neutral alcohol; hand sanitizers; sugarcane wax; and sugarc… Read more
Market Cap & Net Worth: GODAVARIB (GODAVARIB)
GODAVARIB (NSE:GODAVARIB) has a market capitalization of $181.77 Million (₹15.74 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #21360 globally and #1084 in its home market, demonstrating a 10.25% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GODAVARIB's stock price ₹307.60 by its total outstanding shares 51175977 (51.18 Million).
GODAVARIB Market Cap History: 2025 to 2026
GODAVARIB's market capitalization history from 2025 to 2026. Data shows growth from $165.02 Million to $181.77 Million (0.00% CAGR).
GODAVARIB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GODAVARIB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
GODAVARIB's market cap is 0.01 times its annual revenue
8.83x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $165.02 Million | $18.70 Billion | -$234.15 Million | 0.01x | N/A |
Competitor Companies of GODAVARIB by Market Capitalization
Companies near GODAVARIB in the global market cap rankings as of March 18, 2026.
Key companies related to GODAVARIB by market ranking:
- Linde PLC (XETRA:LIN): Ranked #84 globally with a market cap of $187.60 Billion USD ( €182.76 Billion EUR).
- BASF SE NA O.N. (OTCQX:BFFAF): Ranked #461 globally with a market cap of $47.09 Billion USD.
- Shin-Etsu Chemical Co. Ltd (PINK:SHECF): Ranked #470 globally with a market cap of $46.17 Billion USD.
- A. Schulman Inc (PINK:SLMNP): Ranked #826 globally with a market cap of $23.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Linde PLC | XETRA:LIN | $187.60 Billion | €429.40 |
| #461 | BASF SE NA O.N. | OTCQX:BFFAF | $47.09 Billion | $53.46 |
| #470 | Shin-Etsu Chemical Co. Ltd | PINK:SHECF | $46.17 Billion | $24.66 |
| #826 | A. Schulman Inc | PINK:SLMNP | $23.93 Billion | $901.00 |
GODAVARIB Historical Marketcap From 2025 to 2026
Between 2025 and today, GODAVARIB's market cap moved from $165.02 Million to $ 181.77 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹181.77 Million | +10.15% |
| 2025 | ₹165.02 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of GODAVARIB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $181.77 Million USD |
| MoneyControl | $181.77 Million USD |
| MarketWatch | $181.77 Million USD |
| marketcap.company | $181.77 Million USD |
| Reuters | $181.77 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.